The aim is to compare the effectiveness of low-dose dopamine and low-dose nesiritide in managing acute heart failure amongst patients with renal dysfunction.
Randomized trial with participants identified under clinicaltrials.gov Identifier: NCT01132846
Intervention involving low doses of dopamine and nesiritide
Evaluation of heart function and renal dynamics
Low-dose nesiritide resulted in greater improvements in heart function compared to low-dose dopamine.
Lower rates of adverse effects were observed in the nesiritide group.
Descriptive outcomes suggest potential benefits of nesiritide in this specific patient population.